Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kevin P Killeen

Showing results (1-10 of 18) with videos related to

Pageof 2
Sort By:
Human Vaccines|June 27, 2009
Adjuvants and delivery technologiesKevin P Killeen
Human Vaccines & Immunotherapeutics|November 15, 2017
Matrivax profileKevin P Killeen
Microbes & Immunity|February 6, 2025
Progress in the development of an Advax-adjuvanted protein capsular matrix vaccine against typhoid feverNikolai Petrovsky, Kevin P Killeen
Analytical Chemistry|November 14, 2007
Microfluidic gradient formation for nanoflow chip LCReid A Brennen, Hongfeng Yin, Kevin P Killeen
Expert Review of Vaccines|August 7, 2003
Advances in the development of bacterial vector technologySims K Kochi, Kevin P Killeen, Una S Ryan
Vaccine|September 2, 2005
Live, attenuated Salmonella typhimurium vectoring Campylobacter antigensDonata R Sizemore, Beth Warner, Julie Lawrence, et al.
Current Opinion in Molecular Therapeutics|March 1, 2005
Recent advances in the development of live, attenuated bacterial vectorsKenneth L Roland, Steven A Tinge, Kevin P Killeen, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 21, 2015
Conjugate-like immunogens produced as protein capsular matrix vaccinesAnn Thanawastien, Robert T Cartee, Thomas J Griffin, et al.
Human Vaccines & Immunotherapeutics|April 26, 2019
In vitro characterization and preclinical immunogenicity of Typhax, a typhoid fever protein capsular matrix vaccine candidateThomas J Griffin, Ann Thanawastien, Robert T Cartee, et al.
Vaccine|March 27, 2010
Reactogenicity and immunogenicity of live attenuated Salmonella enterica serovar Paratyphi A enteric fever vaccine candidatesKenneth L Roland, Steven A Tinge, Sims K Kochi, et al.
Pageof 2

Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Human Vaccines|June 27, 2009
Adjuvants and delivery technologiesKevin P Killeen
Human Vaccines & Immunotherapeutics|November 15, 2017
Matrivax profileKevin P Killeen
Microbes & Immunity|February 6, 2025
Progress in the development of an Advax-adjuvanted protein capsular matrix vaccine against typhoid feverNikolai Petrovsky, Kevin P Killeen
Analytical Chemistry|November 14, 2007
Microfluidic gradient formation for nanoflow chip LCReid A Brennen, Hongfeng Yin, Kevin P Killeen
Expert Review of Vaccines|August 7, 2003
Advances in the development of bacterial vector technologySims K Kochi, Kevin P Killeen, Una S Ryan
Vaccine|September 2, 2005
Live, attenuated Salmonella typhimurium vectoring Campylobacter antigensDonata R Sizemore, Beth Warner, Julie Lawrence, et al.
Current Opinion in Molecular Therapeutics|March 1, 2005
Recent advances in the development of live, attenuated bacterial vectorsKenneth L Roland, Steven A Tinge, Kevin P Killeen, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 21, 2015
Conjugate-like immunogens produced as protein capsular matrix vaccinesAnn Thanawastien, Robert T Cartee, Thomas J Griffin, et al.
Human Vaccines & Immunotherapeutics|April 26, 2019
In vitro characterization and preclinical immunogenicity of Typhax, a typhoid fever protein capsular matrix vaccine candidateThomas J Griffin, Ann Thanawastien, Robert T Cartee, et al.
Vaccine|March 27, 2010
Reactogenicity and immunogenicity of live attenuated Salmonella enterica serovar Paratyphi A enteric fever vaccine candidatesKenneth L Roland, Steven A Tinge, Sims K Kochi, et al.
Pageof 2